We think all investors should try to buy and hold high quality multi-year winners. While not every stock performs ...

Here is our list of the 11 Best Gene Therapy Stocks to Buy According to Analysts.

The stock has a two hundred day moving average of C$9.35 and traded as high as C$10.49. Advantage Energy shares last traded at C$10.38, with a volume of 524,812 shares trading hands. Analysts Set ...

Provides update on the Company’s transformation and promising portfolio of innovative gene therapy treatments for inherited retinal ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) stock is sliding. The company shared an update on Elevidys (delandistrogene moxeparvovec-rokl), the only approved gene therapy in patients with Duchenne ...

We recently published a list of the 10 Best US Stocks Under $10 to Buy Right Now. In this article, we are going to take a ...

MeiraGTx's innovative gene therapies for ocular diseases & more are backed by strong clinical data and funding. Click here to find out why MGTX stock is a Buy.

Sarepta Therapeutics (SRPT) stock is reeling this week following the death of a 16 ... From Tragedy to Opportunity Sarepta’s Elevidys product is an “adeno-associated virus (AAV)-based” gene therapy ...

Sarepta Therapeutics (SRPT) stock drops 25% as the company reports a patient death linked to Elevidys, its gene therapy developed with Roche (RHHBY). Read more here.

Analysts at HC Wainwright issued their Q1 2026 earnings per share (EPS) estimates for Abeona Therapeutics in a research ...

Click here to discover the next stock our government trade tracker is ... Acute liver injury is a known possible side effect of Elevidys and other AAV-mediated gene therapies and is highlighted ...